Table 1.
Demographic and drug use characteristics and sexual risk behaviors among never-injecting drug users, New York City, 1995–99 and 2005–11.
Table 2.
HIV seroprevalence among never-injecting drug users, New York City, 1995–1999.
Table 3.
HSV-2 seroprevalence by HIV seroprevalence and by gender among never-injecting drug users, New York City, 1995–1999 and 2005–2011.
Figure 1.
HSV-2 and HIV Infection among non-injecting drug users who participated in Beth Israel Medical Center treatment programs by time period: 1995–199 and 2005–2011.
Table 4.
Estimated Population Attributable Risk Percentages of HIV infection for HSV-2 as a Cause of HIV Transmission among Female Never-Injecting Drug Users in New York City, 1995–2011.